| Patents for C07K 19 - Hybrid peptides (29,428) |
|---|
| 12/02/2008 | US7459540 Fibroblast growth factor-like polypeptides |
| 12/02/2008 | US7459293 Polypeptide of given sequence; stimulating immune system and proliferation or development of hematopoietic cells |
| 12/02/2008 | US7459291 Chordin-like molecules and uses thereof |
| 12/02/2008 | US7459172 Drug encapsulation; hollow tubes; drug delivery |
| 12/02/2008 | US7459165 isolated polypeptide consisting of the amino acid sequence set forth as SEQ ID NO:4 from which the signal peptide sequence set forth as SEQ ID NO:38 is deleted; Pseudomonas aeruginosa infection |
| 12/02/2008 | CA2348377C Human orphan g protein-coupled receptors |
| 12/02/2008 | CA2265484C Tumor homing molecules, conjugates derived therefrom, and methods of using same |
| 12/02/2008 | CA2263439C Improved western blot test for the identification of antibodies specific against the hcmv virus |
| 11/27/2008 | WO2008143354A1 Pharmaceutical composition for enzyme replacement therapy |
| 11/27/2008 | WO2008141480A1 Human angiostatin interacting and tumor metastasis involving protein variants and uses thereof |
| 11/27/2008 | WO2008103966A3 Compositions and methods using toll-like receptors and unc93b |
| 11/27/2008 | WO2008039483A3 Modified self-assembling peptides |
| 11/27/2008 | WO2007126847A3 Coadministration of alpha-fetoprotein and a disease modifying anti-rheumatic drug for treating inflammatory arthritic disease |
| 11/27/2008 | US20080293921 HSG (histamine-succinyl-glycine)-binding antibody; binds to a targeted cancer tissue |
| 11/27/2008 | US20080293917 Peptide Purification By Means Of Metal Ion Affinity Chromatography |
| 11/27/2008 | US20080293103 Stress protein compositions and methods for prevention and treatment of cancer and infectious disease |
| 11/27/2008 | US20080292544 Modified Proteins, Designer Toxins, and Methods of Making Thereof |
| 11/27/2008 | CA2690825A1 Fusion molecules and il-15 variants |
| 11/27/2008 | CA2673477A1 Multivalent pneumococcal polysaccharide-protein conjugate composition |
| 11/26/2008 | EP1995318A1 Mammalian cell surface antigens; related reagents |
| 11/26/2008 | EP1995317A1 Mammalian cell surface antigens; related reagents |
| 11/26/2008 | EP1994943A2 Chimeric vaccine antigens against classical swine fever virus |
| 11/26/2008 | EP1994157A1 Recombinant human epo-fc fusion proteins with prolonged half-life and enhanced erythropoietic activity in vivo |
| 11/26/2008 | EP1994152A1 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 11/26/2008 | EP0821732B1 Altered polypeptides with increased half-life |
| 11/26/2008 | CN101311193A Complexes using recombined triple helix support as base |
| 11/26/2008 | CN101311192A Process for high-efficiency expressing sTNFR/Fc fusion protein in yeast and uses thereof |
| 11/26/2008 | CN100436482C Long effective amalgamation protein of erythropoietin of human, preparing and purifying methods |
| 11/26/2008 | CN100436481C Targeted anti-tumour fused protein containing adenovirus E40rf4 protein |
| 11/26/2008 | CN100436480C Platelet glycoprotein IB-alpha variant fusion polypeptides and methods of use thereof |
| 11/25/2008 | US7456276 Peptide purification by means of metal ion affinity chromatography |
| 11/25/2008 | US7456255 Nogo receptor homologs that decrease inhibition of axonal elongation |
| 11/25/2008 | US7456008 Modified virus comprising one or more non-native polypeptides |
| 11/25/2008 | US7455989 AKAP84 and its use for visualization of biological structures |
| 11/25/2008 | US7455978 Protein/solubility folding assessed by structural complementation |
| 11/25/2008 | CA2303416C Repressed trans-activator system for characterization of protein-protein interactions |
| 11/20/2008 | WO2008140060A1 Activated protease indicator |
| 11/20/2008 | WO2008138229A1 Recombinant protein expression system with enhanced yield and immunogenicity |
| 11/20/2008 | WO2008097854A3 Method and substances for treating hpv infection |
| 11/20/2008 | US20080287660 Derived from Xanthomonas campestris pv. campstris; for detecting or preventing a black-rot disease of a crucifer plant, making organic fertilizer or composting and being a biofilter for degradation of organic compounds |
| 11/20/2008 | US20080287348 Soluble Hybrid Prion Proteins And Their Use In The Diagnosis, Prevention And Treatment Of Transmissible Spongiform Encephalopathies |
| 11/20/2008 | US20080286808 Methods for production of unstructured recombinant polymers and uses thereof |
| 11/20/2008 | US20080286288 Vascular endothelial growth factor 2 |
| 11/20/2008 | DE102007023183A1 Verwendung von Autoantikörpern gegen CD28 als prognostischer Marker beim malignen Melanom Use of auto-antibodies to CD28 as a prognostic marker in malignant melanoma |
| 11/20/2008 | CA2668208A1 Hybrid immunoglobulins with moving parts |
| 11/19/2008 | EP1992636A2 Process for correction of a disulfide misfold in Fc molecules |
| 11/19/2008 | EP1991586A1 Chimeric constructs between cancer-homing peptides and cell-penetrating peptides coupled to anticancer drugs and/or diagnostic agent/agents |
| 11/19/2008 | EP1791961A4 Protein production method utilizing yebf |
| 11/19/2008 | EP1330475B1 Neuromedin u delta polypeptides |
| 11/19/2008 | EP1206555B1 Fv antibody construct comprising binding sites for a cd16 receptor and a cd30 surface protein |
| 11/19/2008 | CN101309705A Preventive or therapeutic agent and method for immune disease |
| 11/19/2008 | CN101307110A Preparation method of enhancing peptide fragment immunocompetence and use |
| 11/18/2008 | US7452971 Compositions and methods for modifying toxic effects of proteinaceous compounds |
| 11/18/2008 | US7452685 Nucleotide sequences coding g-protein coupled receptors for identifying modulators of sweet taste transduction; sweetners and flavoring; tastands and food treatment |
| 11/18/2008 | CA2588106A1 Single-domain antibodies and heavy chain antibody against egfr and uses thereof |
| 11/18/2008 | CA2210491C Antagonists of interleukin-15 |
| 11/18/2008 | CA2136230C Clostridium perfringens vaccines |
| 11/18/2008 | CA2095421C Novel amyloid precursor proteins and methods of using same |
| 11/13/2008 | WO2008134876A1 Cancerous disease modifying antibodies |
| 11/13/2008 | WO2008091598A3 CONFORMATION AND ACTIVITY OF Gβ5 COMPLEXES |
| 11/13/2008 | WO2006137838A3 Methods and compositions for diagnosing and preventing a group b streptococcal infection |
| 11/13/2008 | US20080280354 Recombinant poxvirus for chimeric proteins of the human immunodeficiency virus |
| 11/13/2008 | US20080280327 Expression vector comprising nucleotide sequences coding bone morphogenic protein/selectin fusion for use in treatment and prvention of inflammatory diseases |
| 11/13/2008 | US20080280322 Transgenic cell for use as bioreactor in production of human estrogen receptor (HER) specific monoclonal antibody for use in targeted destruction of tumor cells |
| 11/13/2008 | US20080280307 Chimeric Recombinant Antigens of Toxoplasma Gondii |
| 11/13/2008 | CA2684906A1 Cancerous disease modifying antibodies |
| 11/12/2008 | EP1990415A1 Osteoprotegerin |
| 11/12/2008 | EP1990413A1 Screening method for candidate drugs |
| 11/12/2008 | EP1682582A4 Method for the mass production of immunoglobulin constant region |
| 11/12/2008 | EP1465912B1 Chimeric tnf ligands |
| 11/12/2008 | EP1444349B1 Polypeptides of moraxella (branhamella) catarrhalis |
| 11/12/2008 | EP1392831B1 Moraxella(branhamella) catarrhalis antigens |
| 11/12/2008 | EP0977869B2 Lipase and use of same for improving doughs and baked products |
| 11/12/2008 | EP0701569B1 Improved reagents and methods for the diagnosis and treatment of diabetes and stiff man syndrome |
| 11/12/2008 | CN101302256A Novel recombinant fusion molecule and antineoplastic treatment function thereof |
| 11/12/2008 | CN101302255A Matrix metalloproteinase targeted recombined human tumor necrosis factor and preparation thereof |
| 11/12/2008 | CN100432107C Protein for promoting erythrocyte growth factor activity and its use |
| 11/12/2008 | CN100432105C Humanized antibody (H14.18) of the mouse 14.18 antibody binding to GD2 and its fusion with 1L-2 |
| 11/11/2008 | US7449322 Avian leukosis viruses and polypeptide display |
| 11/11/2008 | US7449188 Recombinant oligometric protein complexes with enhanced immunogenic potential |
| 11/11/2008 | US7449187 Alkaline protease from Bacillus gibsonii (DSM 14391) and washing and cleaning products comprising said alkaline protease |
| 11/11/2008 | US7449176 Treatment of inflammatory bowel disease with IFN-γ inhibitors |
| 11/06/2008 | WO2008134731A1 Hybrid block copolymer micelles with mixed stereochemistry for encapsulation of hydrophobic agents |
| 11/06/2008 | WO2008132568A2 Fusion proteins binding to growth factors |
| 11/06/2008 | WO2008052490A3 Peptide chimeric molecules having antiviral properties against viruses of the flaviviridae family |
| 11/06/2008 | WO2008014382A3 System and method for controlling g-protein coupled receptor pathways |
| 11/06/2008 | CA2685400A1 Production of high mannose proteins in plant culture |
| 11/06/2008 | CA2685350A1 Hybrid block copolymer micelles with mixed stereochemistry for encapsulation of hydrophobic agents |
| 11/05/2008 | EP1988166A1 Human Toll-like receptor proteins, related reagents and methods |
| 11/05/2008 | EP1988102A1 Growth factor homolog ZVEGF3 |
| 11/05/2008 | EP1988097A1 Compositions and methods for the therapy and diagnosis of prostate cancer |
| 11/05/2008 | EP1987057A2 Peptide aptamer for neutralizing the binding of platelet antigene specific antibodies and diagnostic and therapeutic applications containing the same |
| 11/05/2008 | CN101300355A Chimeric antigen containing hepatitis c virus polypeptide and Fc fragment for eliciting an immune response |
| 11/05/2008 | CN100430416C New alpha - conantokins, coded polynucleotide and application |
| 11/04/2008 | US7446189 Use as vaccine adjuvants; useful in the treatment of autoimmune diseases and immunosuppression |
| 11/04/2008 | US7446183 Fusion protein comprising growth hormone and growth hormone receptor |
| 11/04/2008 | US7446175 Antibodies to human IL-1β |
| 11/04/2008 | US7446173 amino acid sequence coupled to a non-naturally-occurring polyoxyalkylene glycol at N-terminal end of glycosylated interferon-beta-1a through a coupling group such as aldehyde, maleimide, a vinylsulfone,or haloacetate groups; enhanced activity; Multiple sclerosis; cancer; therapeutical; water solubility |
| 11/04/2008 | US7445781 Inhibits B-cell activation by binding to protein receptor on helper T-cell membrane; treatment of allergy or autoimmune disease |
| 11/04/2008 | CA2182890C Targeted cytolysis of hiv-infected cells by chimeric cd4 receptor-bearing cells |